One consultation, four jurisdictions, and no clear answer about whose law applies
The practitioner is registered nationally. The medicine is regulated by the state. In a telehealth consultation the doctor, the platform, the patient and the dispensing pharmacy can be in four different jurisdictions, and published guidance acknowledges it is complex and confusing to know which law applies.
Steps this would change
Rationale
A practitioner registered by Australian Health Practitioner Regulation Agency may lawfully practise anywhere in Australia. What they may prescribe is governed by state law, and for Schedule 8 controlled medicines the states differ: on permits for ongoing prescribing, on mandatory real-time prescription monitoring checks, and on whether a controlled medicine may be prescribed to a new patient by telehealth at all without a prior face-to-face assessment.
In a physical consultation this never arises, because everyone is in one room. In a telehealth consultation the practitioner may be in one state, the platform incorporated in another, the patient in a third and the dispensing pharmacy in a fourth — and published guidance acknowledges that it is complex and confusing to work out which rules apply.
The cost is borne by the practitioner, who carries personal regulatory risk for getting it wrong, and it lands hardest on exactly the services telehealth exists to enable: cross-border practice into rural and remote areas, after-hours services, and specialist consultations for patients who cannot travel.
This is the sixth instance of the partial-national pattern in this database, after NDIS worker screening, occupational licensing, clinical credentialing, working with children checks and community housing registration.
And it is the instance where the case for harmonisation is weakest, which is why it is filed as an idea. Controlled medicine regulation is a genuine state health and policing function. Diversion and dependence harms are local, are policed locally, and are monitored through state dispensing data. A state that has tightened its rules in response to local harm has a strong claim to keep them.
The narrow proposal is therefore not national uniformity but a clear conflict rule: legislate which jurisdiction's law governs a telehealth prescription — the patient's, in all likelihood, since that is where the medicine is dispensed and consumed — so that a practitioner knows which of eight regimes to comply with before the consultation rather than after.
Uniform substantive rules would be better. A clear answer about which rules apply is achievable, and is the thing missing now.
What is being traded away
A conflict rule pointing to the patient's state means practitioners must know eight regimes rather than one. That is arguably worse than the current ambiguity for a doctor practising nationally, because ambiguity at least permits a good-faith defence. Clarity that resolves against you is not obviously an improvement for the person carrying the risk, and telehealth services operating across every state would need compliance systems for all of them.
Harmonising downward would cost lives. If a conflict rule became a step toward uniform national rules set at the least restrictive common denominator, the result would be easier telehealth access to controlled medicines in the states that have most deliberately restricted it. Opioid and benzodiazepine harm is the reason those restrictions exist, and the states that tightened first did so after deaths. This entry should not be cited in support of that outcome.
Telehealth prescribing of controlled medicines is the highest-risk case for telehealth generally. The restriction on prescribing S8 to a new patient by telehealth without a face-to-face assessment is not bureaucratic caution — it is the specific control against the specific business model of remote prescribing services. Anything that loosens it needs a much stronger evidence base than a process database can offer.
And the measured saving is trivial and probably wrong. Fourteen days on a step that is optional and off the critical path of a four-day process. The real cost here is regulatory uncertainty carried by practitioners and services that consequently do not offer cross-border care at all — a suppression effect that does not appear in any elapsed time and that nobody has measured.
Precedent
Real-time prescription monitoring now operates in most states, and the national registration of practitioners already demonstrates that a profession can be regulated once for the whole country. The components of a national view of controlled prescribing exist as state systems.
Sources
- State and territory Schedule 8 prescribing requirements, including permits for ongoing prescribing, mandatory real-time prescription monitoring, and restrictions on prescribing to new patients via telehealth
- Victorian Department of Health guidance on Schedule 8 poisons and interstate prescriptions
- Medical Board of Australia, guidelines on telehealth consultations with patients